About the Ocular Gene Therapy Laboratory (OGTL) at the ʼһ
Designing The Next Generation Of Gene Therapy Treatments
Founded in 2016 by Daniel M. Lipinski, DPhil, the Ocular Gene Therapy Laboratory (OGTL) aims to develop broadly applicable gene-based therapeutics to prevent human blindness arising from neurodegenerative or vascular diseases affecting the retina. Consisting of faculty, students and staff from a diverse range of academic backgrounds, the OGTL laboratory takes a highly multidisciplinary and collaborative approach toward research, working with basic science and clinical investigators worldwide to identify novel therapies for currently untreatable conditions that result in vision loss in humans. Learn More
Research
Our research focuses on developing broadly applicable gene-based therapeutics to prevent human blindness arising from neurodegenerative or vascular diseases affecting the retina.
Find out more about our researchNews
We are proud of the recognition our team receives for the trailblazing work they do.
View our recent news updatesCareers
Interested in joining our team? We’d love to hear from you.
View resources for interested candidates